Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cell Strain
27%
Cetuximab
18%
Cisplatin
18%
Clinically Significant
9%
Degree of Differentiation
9%
Drug Sensitivity
9%
Formalin-fixed Paraffin-embedded
9%
Frozen Tissue
9%
Growth Inhibition
9%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
100%
High Consistency
9%
Human Papillomavirus
100%
Human Papillomavirus Negative
100%
Immunodeficient Mice
9%
Inverse Correlation
9%
Newly Diagnosed
9%
P16 Staining
9%
Passage Cells
18%
Patient Tumor
9%
Preclinical Testing
9%
Radiation Therapy
9%
Rapid Test
9%
Response to Cancer Therapy
9%
Response to Radiation
9%
Spearman Correlation
9%
Strong Correlation
9%
Therapeutic Response
9%
Tumor
9%
Tumor Differentiation
9%
Tumor Growth Rate
9%
Tumor Growth Response
9%
Tumor Marker
9%
Tumor Specimens
18%
Tumorgrafts
100%
Medicine and Dentistry
Cancer
16%
Cancer Therapy
16%
Cell Strain
50%
Cetuximab
33%
Cisplatin
33%
Drug Sensitivity
16%
Formaldehyde
16%
Growth Inhibition
16%
Head and Neck Squamous Cell Carcinoma
100%
Neoplasm
50%
P16
33%
Protein P53
16%
Radiation Therapy
16%
Radiation Treatment
16%
Rapid Test
16%
Treatment Response
16%
Tumor
16%
Tumor Differentiation
16%
Tumor Marker
16%
Tumor Progression
16%
Wart Virus
100%
Nursing and Health Professions
Cancer Therapy
25%
Cetuximab
50%
Cisplatin
50%
Experimental Design
25%
Formaldehyde
25%
Head and Neck Squamous Cell Carcinoma
100%
Neoplasm
75%
Protein P53
25%
Rapid Test
25%
Staining
25%
Treatment Response
25%
Tumor Differentiation
25%
Tumor Growth
25%
Tumor Marker
25%
Immunology and Microbiology
Cell Strain
50%
Cetuximab
33%
Drug Sensitivity
16%
Growth Inhibition
16%
Neck
100%
P53
16%
Squamous Cell
100%
Staining
16%
Wart Virus
100%